Aerie Pharmaceuticals

Aerie Pharmaceuticals

Aerie Pharmaceuticals

Aerie Pharmaceuticals is focused on developing products for the pharmaceuticaltreatment of glaucoma.
Type
B2c
Founded
2005
Raised
$331.4M
Follow us
Alexa global traffic share
09 Sep 2014
$125,000,000
Post-IPO equity
07 Mar 2011
$41,364,965
Venture capital (Series B)